Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioMarin Pharmaceutical Inc. buy Citigroup Inc.

BioMarin Pharmaceutical Inc.
Start price
€51.44
16.07.26 / 50%
Target price
€66.28
16.07.27
Performance (%)
13.22%
Price
€58.22
14.08.26
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ currently has a performance of 13.22%. This prediction currently runs until 16.07.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
BioMarin Pharmaceutical Inc. 5.547% 5.547%
iShares Core DAX® 0.437% 5.897%
iShares Nasdaq 100 1.057% 0.920%
iShares Nikkei 225® 1.769% 1.228%
iShares S&P 500 0.368% 1.920%

Comments by Citigroup_Inc_ for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) 13.22%
Target price 66.280
Change
Ends at 16.07.27

BioMarin Pharmaceutical (BMRN) had its price target raised by Citigroup Inc. from $75.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat

Citigroup Inc. 
0
Report Share
16.07.26

Stopped prediction by Citigroup_Inc_ for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€42.91
19.05.26
€64.43
19.05.27
35.68%
14.08.26

Citigroup Inc. 
19.05.26 50%